Ninety One UK Ltd, a registered investment adviser, initiated a new position in Edwards Lifesciences Corporation (NYSE:EW) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 7,734,946 shares of the Healthcare company, valued at approximately $659.4M as of the filing date.
Edwards Lifesciences Corporation's stock currently trades at $84.03 with a market capitalization of $49.5B.
